Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hetty E Carraway

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Hematology. American Society of Hematology. Education Program|December 5, 2025
Updates in low/intermediate-risk MDSHetty E Carraway
Hematology. American Society of Hematology. Education Program|December 4, 2016
Treatment options for patients with myelodysplastic syndromes after hypomethylating agent failureHetty E Carraway
Journal of Hematology & Oncology|April 20, 2017
Emerging therapies for acute myeloid leukemiaCaner Saygin, Hetty E Carraway
Cancer Journal (Sudbury, Mass.)|May 17, 2023
Overview of the Management of Higher-Risk Myelodysplastic SyndromesAbhay Singh, Hetty E Carraway
Hematology. American Society of Hematology. Education Program|December 4, 2020
Therapy for lower-risk MDSHetty E Carraway, Caner Saygin
Best Practice & Research. Clinical Haematology|October 11, 2020
Myeloid neoplasms with germline predisposition: Practical considerations and complications in the search for new susceptibility lociHetty E Carraway, Thomas LaFramboise
Blood Reviews|January 11, 2021
Current and emerging strategies for management of myelodysplastic syndromesCaner Saygin, Hetty E Carraway
Current Treatment Options in Oncology|June 25, 2024
Treatment of Relapsed Acute Lymphocytic Leukemia in Adult PatientsJohn C Molina, Hetty E Carraway
Arthritis & Rheumatology (Hoboken, N.J.)|April 27, 2025
Expert Perspectives on a Clinical Challenge: Hematologic Malignancies and VasculitisMichelle L Robinette, Hetty E Carraway
Current Opinion in Hematology|February 24, 2010
Novel approaches for myelodysplastic syndromes: beyond hypomethylating agentsArturo Loaiza-Bonilla, Steven D Gore, Hetty E Carraway
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Hematology. American Society of Hematology. Education Program|December 5, 2025
Updates in low/intermediate-risk MDSHetty E Carraway
Hematology. American Society of Hematology. Education Program|December 4, 2016
Treatment options for patients with myelodysplastic syndromes after hypomethylating agent failureHetty E Carraway
Journal of Hematology & Oncology|April 20, 2017
Emerging therapies for acute myeloid leukemiaCaner Saygin, Hetty E Carraway
Cancer Journal (Sudbury, Mass.)|May 17, 2023
Overview of the Management of Higher-Risk Myelodysplastic SyndromesAbhay Singh, Hetty E Carraway
Hematology. American Society of Hematology. Education Program|December 4, 2020
Therapy for lower-risk MDSHetty E Carraway, Caner Saygin
Best Practice & Research. Clinical Haematology|October 11, 2020
Myeloid neoplasms with germline predisposition: Practical considerations and complications in the search for new susceptibility lociHetty E Carraway, Thomas LaFramboise
Blood Reviews|January 11, 2021
Current and emerging strategies for management of myelodysplastic syndromesCaner Saygin, Hetty E Carraway
Current Treatment Options in Oncology|June 25, 2024
Treatment of Relapsed Acute Lymphocytic Leukemia in Adult PatientsJohn C Molina, Hetty E Carraway
Arthritis & Rheumatology (Hoboken, N.J.)|April 27, 2025
Expert Perspectives on a Clinical Challenge: Hematologic Malignancies and VasculitisMichelle L Robinette, Hetty E Carraway
Current Opinion in Hematology|February 24, 2010
Novel approaches for myelodysplastic syndromes: beyond hypomethylating agentsArturo Loaiza-Bonilla, Steven D Gore, Hetty E Carraway
Pageof 9